Article 57 product data
Submitted by Anonymous (not verified) on 10 December 2025 - 11:00
Article 57 product data
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 27/02/2011, Revision: 36, Status: Authorised
Submitted by Anonymous (not verified) on 10 December 2025 - 9:55
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 27/02/2011, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 10 December 2025 - 8:17
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 6, Status: Authorised
Medical devices
Submitted by Anonymous (not verified) on 10 December 2025 - 8:16
Medical devices
List of medicines under additional monitoring
Submitted by Anonymous (not verified) on 10 December 2025 - 8:03
List of medicines under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 10 December 2025 - 8:01
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 10 December 2025 - 8:00
List of medicinal products under additional monitoring
Dextrans - Scientific guideline
Submitted by Anonymous (not verified) on 9 December 2025 - 16:08
Dextrans - Scientific guideline
EMA/PE/0000182447
Submitted by Anonymous (not verified) on 9 December 2025 - 15:30
EMA/PE/0000182447
EMA/PE/0000183373
Submitted by Anonymous (not verified) on 9 December 2025 - 15:29
EMA/PE/0000183373